Oncology & Cancer

FDA approves 'game changer' immunotherapy drug for bladder cancer

A new immunotherapy drug, atezolizumab, has been approved for patients with metastatic urothelial carcinoma, a type of bladder cancer. The drug represents the first new treatment for this form of the disease in more than ...

page 2 from 2